Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.280
0.00 (0.00%)
At close: Sep 20, 2024, 4:00 PM
1.270
-0.010 (-0.76%)
After-hours: Sep 20, 2024, 5:06 PM EDT
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $7.10 million as of September 20, 2024. Its market cap has decreased by -40.87% in one year.
Market Cap
7.10M
Enterprise Value
4.15M
1-Year Change
-40.87%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $55.50M to $7.10M, a decrease of -87.21%. That is a compound annual growth rate of -50.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2024 | 7.10M | 69.05% |
| Dec 29, 2023 | 4.20M | -82.86% |
| Dec 30, 2022 | 24.50M | -78.36% |
| Dec 31, 2021 | 113.20M | 103.96% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nexalin Technology | 7.42M |
| Coeptis Therapeutics Holdings | 7.35M |
| NuCana | 7.32M |
| Aptose Biosciences | 7.21M |
| Cyclerion Therapeutics | 7.12M |
| Kineta | 7.05M |
| Moleculin Biotech | 7.00M |
| Eterna Therapeutics | 6.82M |